STOCK TITAN

Casi Pharmaceuticals Inc (CASI) Debt by Year

CASI

Casi Pharmaceuticals Inc held $5.6M in cash and equivalents at the end of fiscal year 2025, and long-term debt is not reported for that period. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Casi Pharmaceuticals Inc has filed alongside them.

FY2025 annual
Long-Term Debt N/A
Cash & Equivalents $5.6M
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CASI Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY22FY21FY20
Long-Term DebtN/AN/A$18.9MN/AN/AN/A
Cash & Equivalents$5.6M-58.2%$13.5M-21.2%$17.1M-63.7%$47.1M+21.7%$38.7MN/A

CASI Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2510-KQ4'2410-KQ4'23Q4'22Q4'21
Long-Term DebtN/AN/A$18.9MN/AN/A
Cash & Equivalents$5.6M-58.2%$13.5M-21.2%$17.1M-63.7%$47.1M+21.7%$38.7M

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Casi Pharmaceuticals Inc financials

Frequently Asked Questions

What was Casi Pharmaceuticals Inc's long-term debt in fiscal year 2025?

Casi Pharmaceuticals Inc held $5.6M in cash and equivalents at the end of fiscal year 2025, and long-term debt is not reported for that period.

What does long-term debt mean on a financial statement?

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Casi Pharmaceuticals Inc (CASI) reported on that line in every period on record.